Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Cannabinoid Receptor I ELISA Kit (AC3366)
Cat.#: ASET-1955
Specifications
Description Rat Cannabinoid Receptor I ELISA Kit allows for the in vitro quantitative determination of rat Cannabinoid Receptor I concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2433 Human Calnexin ELISA Kit (AC3844) Quantitative inquiry ASET-2247 Human PON1 ELISA Kit (AC3658) Quantitative inquiry ASET-1793 Human GDF11 ELISA Kit (AC3204) Quantitative inquiry ASET-1008 Human KCNJ4 ELISA Kit (AC2419) Quantitative inquiry ASET-1890 Mouse GDNF ELISA Kit (AC3301) Quantitative inquiry ASET-1698 Human Copeptin ELISA Kit (AC3109) Quantitative inquiry ASET-1386 Mouse NMDAR1 ELISA Kit (AC2797) Quantitative inquiry ASET-1499 Human Neuroligin 1 ELISA Kit (AC2910) Quantitative inquiry ASET-1038 Rat ULK1 ELISA Kit (AC2449) Quantitative inquiry ASET-2413 Mouse Has3 ELISA Kit (AC3824) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket